Elicio Therapeutics (ELTX) EBITDA Margin (2020 - 2022)
Elicio Therapeutics (ELTX) reported EBITDA Margin of 1117.76% for Q2 2022, up 203112.0% on a YoY basis from N/an in Q2 2021, and down 28.49% quarter-over-quarter from 869.9% in Q1 2022.
Elicio Therapeutics (ELTX) EBITDA Margin (2020 - 2022) Analysis & Trends
Elicio Therapeutics has reported EBITDA Margin for 3 years, with the latest figure at 1117.76% in Q2 2022.
- For the quarter ending Q2 2022, EBITDA Margin rose 203112.0% year-over-year to 1117.76%; the trailing twelve-month figure through Mar 2023 stood at 4468.15% (down 435684.0% YoY), and the FY2022 full-year result was 1225.9%, down 102833.0% from the prior year.
- EBITDA Margin for Q2 2022 stood at 1117.76%, down from 869.9% in the prior quarter.
- The five-year high for EBITDA Margin was 1308.03% in Q4 2020, with the low at 9876.28% in Q1 2021.
- Historically, EBITDA Margin has averaged 2185.24% across 3 years, with a median of 1117.76% in 2022.
- Annual changes were most pronounced in 2021 — EBITDA Margin tumbled 124891 bps — and 2022, when it jumped 900638 bps.
- Elicio Therapeutics' EBITDA Margin stood at 1308.03% in 2020, then tumbled by 95 bps to 59.12% in 2021, then plunged by 1991 bps to 1117.76% in 2022.
- The last three EBITDA Margin figures came in at 1117.76% (Q2 2022), 869.9% (Q1 2022), and 59.12% (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1,117.76% |
| Mar 31, 2022 | -869.90% |
| Dec 31, 2021 | 59.12% |
| Sep 30, 2021 | -1,065.62% |
| Jun 30, 2021 | -3,148.89% |
| Mar 31, 2021 | -9,876.28% |
| Dec 31, 2020 | 1,308.03% |
| Sep 30, 2020 | -2,138.69% |
| Jun 30, 2020 | -2,817.15% |